| Net Cash Provided by (Used in) Operating Activities |
$229,827 |
USD |
93% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$79,883 |
USD |
-103% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$135,586 |
USD |
-80% |
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
2,000,000,000 |
shares |
0% |
Q4 2025 |
Q3 2026 |
| Common Stock, Shares, Issued |
518,831,367 |
shares |
0% |
Q4 2025 |
Q3 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
Q3 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$440,358 |
USD |
24% |
Q2 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$777,737 |
USD |
223% |
Q4 2025 |
Q3 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$102,448 |
USD |
31% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$352,189 |
USD |
2.8% |
Q4 2025 |
Q3 2026 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.25 |
pure |
0% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Gross |
$476,484 |
USD |
11% |
Q4 2025 |
Q3 2026 |
| Depreciation |
$166,470 |
USD |
60435% |
Q2 2025 |
Q1 2026 |
| Payments to Acquire Property, Plant, and Equipment |
$135,586 |
USD |
80% |
Q2 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$3,526,257 |
USD |
|
Q4 2025 |
Q3 2026 |
| Property, Plant and Equipment, Gross |
$21,672 |
USD |
|
Q3 2024 |
Q3 2024 |
| Deferred Income Tax Expense (Benefit) |
$9,670 |
USD |
-80% |
Q2 2025 |
Q1 2026 |
| Current Income Tax Expense (Benefit) |
$39,482 |
USD |
752% |
Q2 2025 |
Q1 2026 |
| Additional Paid in Capital |
$39,905,228 |
USD |
133% |
Q1 2024 |
Q1 2024 |
| Amortization of Intangible Assets |
$81 |
USD |
|
Q1 2024 |
Q1 2024 |
| Depreciation, Depletion and Amortization |
$22,063 |
USD |
-2.8% |
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$124,295 |
USD |
45% |
Q4 2025 |
Q3 2026 |